SCHEMBL4616873

SCHEMBL4616873

CC(C)Oc1cc(/C=C/S(=O)(=O)OC(N)=O)n(Cc2ccc(Cl)cc2Cl)n1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 17/20 0.60
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616876 1.00 PPARG (0.60) PPARGNPC1
SCHEMBL4613186 0.87 PPARG (0.46) PPARGNPC1
SCHEMBL4613183 0.87 PPARG (0.46) PPARGNPC1
SCHEMBL3211393 0.87 PPARG (0.61) PPARG
SCHEMBL3211375 0.87 PPARG (0.61) PPARG
SCHEMBL4614129 0.86 PPARG (0.53) PPARG
SCHEMBL4614130 0.86 PPARG (0.53) PPARG
SCHEMBL3208024 0.84 PPARG (0.67) PPARG
SCHEMBL3208031 0.84 PPARG (0.67) PPARG
SCHEMBL3215461 0.82 PPARG (0.67) PPARGNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed